Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.
E
E
Goffin
Y
Y
Horsmans
C
C
Cornu
J P
JP
Squifflet
Y
Y
Pirson
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D019259:Lamivudine